NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Tianjin Haida Venture Capital Management

Tianjin Haida Venture Capital Management

Overview

Tianjin Haida Venture Capital Management is a venture capital firm that focuses on investments in the medical health and intelligent manufacturing sectors.

Year Founded

2007

Portfolio Companies

17

Investments

Tianjin Haida Venture Capital Management investments
CompanyDateStageLead
Metware BiotechnologyApr 2024Series BLead
Brite SemiconductorAug 2020Series D-
广州瑞通生物科技有限公司Jul 2020Series B ExtensionCo-investor
Xpeedic TechnologyNov 2019Series ACo-investor
Zhejiang Baichen Medical Technology Co., Ltd.Oct 2019VC RoundCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersTianjin
Year Founded2007

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.